Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVIDAI: Feasibility Study of Adhera® Fatigue Digital Program for Patients With Long COVID-related Fatigue

NCT05631171 is registered in ClinicalTrials.gov with Adhera Health, Inc. as lead sponsor.

NCT NCT05631171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05631171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVIDAI: Feasibility Study of Adhera® Fatigue Digital Program for Patients With Long COVID-related Fatigue
Lead sponsor
Adhera Health, Inc.
Phase
Not applicable
Overall status
Completed
Start date
December 13, 2022
Completion date
June 30, 2023
Enrollment
58 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fatigue, post-acute covid19 syndrome